Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemia.
Lane AA, Garcia JS, Raulston EG, Garzon JL, Galinsky I, Baxter EW, Leonard R, DeAngelo DJ, Luskin MR, Reilly CR, Stahl M, Stone RM, Vedula RS, Wadleigh MM, Winer ES, Mughal T, Brooks C, Gupta IV, Stevenson KE, Neuberg DS, Ren S, Keating J, Konopleva M, Stein A, Pemmaraju N. Lane AA, et al. Among authors: winer es. Blood Adv. 2024 Feb 13;8(3):591-602. doi: 10.1182/bloodadvances.2023011721. Blood Adv. 2024. PMID: 38052038 Free PMC article. Clinical Trial.
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia.
Luskin MR, Murakami MA, Keating JH, Flamand Y, Winer ES, Garcia JS, Stahl M, Stone RM, Wadleigh M, Jaeckle SL, Hagopian E, Weinstock DM, Liegel J, McMasters M, Wang ES, Stock W, DeAngelo DJ. Luskin MR, et al. Among authors: winer es. Blood. 2024 Oct 7:blood.2024025800. doi: 10.1182/blood.2024025800. Online ahead of print. Blood. 2024. PMID: 39374521
Venetoclax plus low intensity chemotherapy for adults with acute lymphoblastic leukemia.
Luskin MR, Shimony S, Keating JH, Winer ES, Garcia JS, Stone RM, Jabbour EJ, Flamand Y, Stevenson K, Ryan JA, Zeng Z, Letai A, Konopleva MY, Jain N, DeAngelo DJ. Luskin MR, et al. Among authors: winer es. Blood Adv. 2024 Nov 15:bloodadvances.2024014405. doi: 10.1182/bloodadvances.2024014405. Online ahead of print. Blood Adv. 2024. PMID: 39546748
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings.
Garcia JS, Flamand Y, Penter L, Keng M, Tomlinson BK, Mendez LM, Koller P, Cullen N, Arihara Y, Pfaff K, Wolff JO, Brunner AM, Galinsky I, Bashey A, Antin JH, Cutler C, Ho V, Jonas BA, Luskin MR, Wadleigh M, Winer ES, Savell A, Leonard R, Robertson T, Davids MS, Streicher H, Rodig SJ, Ritz J, Wu CJ, DeAngelo DJ, Neuberg D, Stone RM, Soiffer RJ. Garcia JS, et al. Among authors: winer es. Blood. 2023 Apr 13;141(15):1884-1888. doi: 10.1182/blood.2022017686. Blood. 2023. PMID: 36332187 Free PMC article.
CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias.
Vedula RS, Karp HQ, Koob J, Lim F, Garcia JS, Winer ES, Luskin MR, Ghiaur G, Kim AS, Beppu LW, Sala-Torra O, Radich J, Gootenberg J, Abudayyeh O, Zhang F, Lindsley RC. Vedula RS, et al. Among authors: winer es. Blood. 2024 Sep 19;144(12):1290-1299. doi: 10.1182/blood.2023022908. Blood. 2024. PMID: 38976877
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers.
Abaza Y, Winer ES, Murthy GSG, Shallis RM, Matthews AH, Badar T, Geramita EM, Kota VK, Swaroop A, Doukas P, Bradshaw D, Helenowski IB, Liu Y, Zhang H, Im A, Litzow MR, Perl AE, Atallah E, Altman JK. Abaza Y, et al. Among authors: winer es. Am J Hematol. 2024 Apr;99(4):606-614. doi: 10.1002/ajh.27231. Epub 2024 Feb 11. Am J Hematol. 2024. PMID: 38342997
AML in the Elderly - When less may be more.
Winer ES, Stone RM. Winer ES, et al. Curr Oncol Rep. 2024 Nov;26(11):1502-1510. doi: 10.1007/s11912-024-01604-8. Epub 2024 Oct 17. Curr Oncol Rep. 2024. PMID: 39417945 Review.
Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen.
Shimony S, Raman HS, Flamand Y, Keating J, Paolino JD, Valtis YK, Place AE, Silverman LB, Sallan SE, Vrooman LM, Brunner AM, Neuberg DS, Galinsky I, Garcia JS, Winer ES, Wadleigh M, Stone RM, Connors JM, DeAngelo DJ, Luskin MR. Shimony S, et al. Among authors: winer es. Blood Cancer J. 2024 Oct 31;14(1):191. doi: 10.1038/s41408-024-01178-5. Blood Cancer J. 2024. PMID: 39482298 Free PMC article.
105 results